1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II

Arch Pharm (Weinheim). 2004 May;337(5):247-58. doi: 10.1002/ardp.200300782.

Abstract

New 1, 2, 4-Triazine N-oxide and N, N'-dioxide derivatives were synthesized in order to obtain compounds as selective hypoxic cell cytotoxins. The starting heterocycles have been prepared using a standard microwave oven in a clean and good-yielded process. The reactivity of methyl-1, 2, 4-triazine N(4)-oxide and N(1), N(4)-dioxide with different electrophilic agents has been studied. The desired products were obtained only when iminium electrophiles were employed. The regioselectivity of this process has been studied by means of experimental and theoretical (at ab initio level) procedures. Theoretically was expected that the most stable intermediates where the benzylic-like anion from position 5. A fact which agreed with the experimental observed regioselectivity. The new compounds were tested for their cytotoxicity in oxia and hypoxia. Some of them proved to be less active in hypoxic conditions than tirapazamine, 3-amino-benzo[1, 2-e]1, 2, 4-triazine N(1), N(4)-dioxide. Derivative 19, 6-methyl-5-[2-(5-nitrothienyl)ethenyl)-1, 2, 4-triazine N(4)-oxide, was the most cytotoxic compound, but it was non-selective.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Cell Hypoxia
  • Cell Line
  • Cricetinae
  • Cricetulus
  • Cyclic N-Oxides / chemical synthesis*
  • Cyclic N-Oxides / pharmacology
  • Drug Design
  • Molecular Structure
  • Stereoisomerism
  • Structure-Activity Relationship
  • Triazines / chemical synthesis*
  • Triazines / pharmacology
  • Tumor Stem Cell Assay

Substances

  • Antineoplastic Agents
  • Cyclic N-Oxides
  • Triazines
  • 1,2,4-triazine